Challenges in Clinical Electrocardiography.
Unadjusted Rates of 30-day Mortality, Mechanical Ventilation, and ICU Stay Among Solid Cancer and Hematologic Patients Stratified by Treatment Within 3 Months from COVID-19 Diagnosis Unadjusted Rates (With 95% CI) of 30-day Mortality, Mechanical Ventilation, ICU Stay, and Hospitalization According to 2020 Time PeriodĮFigure 4. Unadjusted Rates (With 95%CI) of 30-day Mortality, Mechanical Ventilation, ICU Stay, and Hospitalization Among Non-Cancer Patients, Patients With Cancer Not Recently Treated and Patients With Cancer Recently TreatedĮFigure 3. Flow Diagram of Cohort Selection Using the Optum® De-identified COVID-19 Electronic Health Record DatasetĮFigure 2. Adverse Outcomes Among Matched (1:5) Cohorts Via Age-Gender-Comorbidity MatchĮFigure 1. Logistic Regression Models Evaluating Adverse Outcomes Among 3,291 Patients With Hematological Malignancies and COVID-19ĮTable 6. Logistic Regression Models Evaluating Adverse Outcomes Among 10,996 Patients With Solid Tumors and COVID-19ĮTable 5. Recent Treatment Among Patients With Cancer (n = 14,287)ĮTable 4. Logistic Regression Models Evaluating Adverse Outcomes Among 75,792 Patients Who Were Hospitalized Within 30 Days After COVID-19 DiagnosisĮTable 3. Codes Used to Identify COVID-19 Test, Cancer Diagnosis, Cancer Treatment and Adverse Outcomes and Other Variables of InterestĮTable 2.